1
|
Liu X, Wang F, Meng Y, Zhao L, Shi W, Wang X, He Z, Chao J, Li C. Electrochemical/visual microfluidic detection with a covalent organic framework supported platinum nanozyme-based device for early diagnosis of pheochromocytoma. Biosens Bioelectron 2022; 207:114208. [PMID: 35344731 DOI: 10.1016/j.bios.2022.114208] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Revised: 03/18/2022] [Accepted: 03/19/2022] [Indexed: 02/08/2023]
Abstract
The development of smart, portable, and sensitive devices for the monitoring of circulating tumor cells (CTCs) is essential to diagnose several diseases, including pheochromocytoma (PCC). Therefore, in this study, a dual-mode (electrochemical/visual) microfluidic device was designed for the rapid and sensitive detection of PCC-CTCs using a microfluidic chip for automatic cell sampling and detection and a smartphone-based three-dimensional-printed accessory for signal output analysis. The device was employed to capture and identify PCC-CTCs via specific immunogenic binding to the norepinephrine transporter and somatostatin receptor, which are overexpressed on the surface of PCC cells. Specifically, targeted-modified magnetic particles were used to capture and separate PCC-CTCs from peripheral blood; then, similarly modified covalent organic framework based nanozymes (COF@Pt) were used as peroxidase mimics to amplify the electrochemical response from H2O2 reduction and catalyze the oxidation of 3,3',5,5'-tetramethylbenzidine by hydroxyl radicals in the presence of the PCC cells to enable visual quantification. Using the prepared microfluidic device, a low detection limit of 1 cell mL-1 at a signal-to-noise ratio of 3 and a wide linear range of 2 to 105 cells mL-1 were achieved. Overall, this work demonstrates a portable, sensitive, and visual platform for PCC diagnostics that meets the requirement for quick and precise point-of-care diagnostics.
Collapse
Affiliation(s)
- Xiaoya Liu
- Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China; Cell and Biomolecule Recognition Research Center, School of Science, China Pharmaceutical University, Nanjing, 211198, China
| | - Fei Wang
- Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China; Cell and Biomolecule Recognition Research Center, School of Science, China Pharmaceutical University, Nanjing, 211198, China
| | - Yang Meng
- Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China; Cell and Biomolecule Recognition Research Center, School of Science, China Pharmaceutical University, Nanjing, 211198, China
| | - Liping Zhao
- Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China; Cell and Biomolecule Recognition Research Center, School of Science, China Pharmaceutical University, Nanjing, 211198, China
| | - Wenjing Shi
- Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China; Cell and Biomolecule Recognition Research Center, School of Science, China Pharmaceutical University, Nanjing, 211198, China
| | - Xun Wang
- Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China; Cell and Biomolecule Recognition Research Center, School of Science, China Pharmaceutical University, Nanjing, 211198, China
| | - Zikang He
- Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China; Cell and Biomolecule Recognition Research Center, School of Science, China Pharmaceutical University, Nanjing, 211198, China
| | - Jie Chao
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China
| | - Caolong Li
- Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing, 211198, China; Cell and Biomolecule Recognition Research Center, School of Science, China Pharmaceutical University, Nanjing, 211198, China.
| |
Collapse
|